Abstract
Discussion
The title compound is ab iologically active derivative of chalcone. Chalcones (1,3-diaryl-prop-2-en-1-ones) are Michael acceptors and constitute an important class of natural products belonging to the flavonoid family, which display interesting biological activities including anticancer, antimalarial, antiinflammatory, antileishmanial, antituberclulosis,n itric oxide inhibition, antimitotic, analgesic, antipyretic, antioxidant, antibacterial, anti-HIV, antifungal, and antiprotozoal activities [3] [4] [5] [6] . Due to their abundance in plants and easeofsynthesis, this class of compounds has generated great interest for possible therapeutic uses [7, 8] . As apart of our research for novel antitumor agents, we designed and synthesized aseries of chalcones analogues, and the biological activity evaluation indicated that someo ft hese compounds are potent antitumor and antibacterial agents [1, 2] .
The title molecule consists of two benzene rings linked by a propenone chain at the 1,3-position. The bond lengths within the phenyl rings are between 1.382(2) Åand 1.392(2) Å, which highlights the aromatic character. The two independent planar benzene ring systems are separated by a,b-unsaturated ketone and this unique structureisresponsible forvarious activities of these molecules. The olefinic double bond (d(C8=C9) =1.321(3)Å)is in E-configuration andisCsp 2 hybridized. The dihedral angle between two benzene rings is 11.1(1)°. It is clear that the two aromatic rings in the molecule are linked via the -CH=CH-moiety and each ring is twisted relative to the other by an angle of 11.1(1)°. Themolecule is therefore almost planar. The most important feature for the packing of (E)- 
